Published on 9 May 2024 on Simply Wall St. via Yahoo Finance
Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting...
Investors in Axsome Therapeutics, Inc. (NASDAQ:AXSM) had a good week, as its shares rose 2.0% to close at US$75.68 following the release of its first-quarter results. The results don't look great, especially considering that statutory losses grew 17% toUS$1.44 per share. Revenues of US$74,999,000 did beat expectations by 2.9%, but it looks like a bit of a cold comfort. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
View our latest analysis for Axsome Therapeutics
